We are live on ! Find out more
CLOS

Compagnie Lombard Odier SCmA Portfolio holdings

AUM $9.25B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+27.04%
3 Year Est. Return
+108.78%
5 Year Est. Return
+129.43%
10 Year Est. Return
+503.05%
AUM
$3.42B
AUM Growth
-$9.28M
Cap. Flow
-$73.2M
Cap. Flow %
-2.14%
Top 10 Hldgs %
32.43%
Holding
900
New
2
Increased
177
Reduced
242
Closed
88

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$35.9M
2
DXCM icon
DexCom
DXCM
+$27.4M
3
AGN
Allergan plc
AGN
+$19.8M
4
NBL
Noble Energy, Inc.
NBL
+$16.5M
5
PANW icon
Palo Alto Networks
PANW
+$15.9M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$13.4M
2
CVX icon
Chevron
CVX
+$13.2M
3
MET icon
MetLife
MET
+$12.5M
4
MRK icon
Merck
MRK
+$7.01M
5
JPM icon
JPMorgan Chase
JPM
+$6.12M

Sector Composition

Rank Sector Weight
1 Healthcare 16.53%
2 Communication Services 13.18%
3 Financials 12.43%
4 Consumer Staples 12.03%
5 Technology 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NMR icon
701
Nomura Holdings
NMR
$29.1B
$13K ﹤0.01%
2,150
-43,510
-95% -$232K
GPL
702
DELISTED
Great Panther Mining Limited
GPL
$13K ﹤0.01%
790
– –
CSIQ icon
703
Canadian Solar
CSIQ
$1.08B
$12K ﹤0.01%
971
– –
CFMS
704
DELISTED
Conformis, Inc. Common Stock
CFMS
$12K ﹤0.01%
60
+20
+50% +$4.43K
OMED
705
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$12K ﹤0.01%
1,500
– –
RGLS
706
DELISTED
Regulus Therapeutics
RGLS
$11K ﹤0.01%
42
+17
+68% +$5.53K
LXRX icon
707
Lexicon Pharmaceuticals
LXRX
$1.1B
$10K ﹤0.01%
700
– –
NBIX icon
708
Neurocrine Biosciences
NBIX
$16.6B
$10K ﹤0.01%
260
– –
TTWO icon
709
Take-Two Interactive
TTWO
$46.1B
$10K ﹤0.01%
200
-700
-78% -$33.1K
ZIXI
710
DELISTED
Zix Corporation
ZIXI
$10K ﹤0.01%
2,000
– –
CTLP
711
DELISTED
Cantaloupe
CTLP
$9K ﹤0.01%
2,000
– –
FTV icon
712
Fortive
FTV
$18.6B
$9K ﹤0.01%
268
-495
-65% -$16.4K
MFIC icon
713
MidCap Financial Investment
MFIC
$804M
$9K ﹤0.01%
493
– –
XRX icon
714
Xerox
XRX
$425M
$9K ﹤0.01%
380
– –
ABMD
715
DELISTED
Abiomed Inc
ABMD
$9K ﹤0.01%
80
– –
ARRY
716
DELISTED
Array Biopharma Inc
ARRY
$9K ﹤0.01%
1,000
-2,500
-71% -$18.4K
SHPG
717
DELISTED
Shire pic
SHPG
$9K ﹤0.01%
52
– –
CF icon
718
CF Industries
CF
$17.3B
$8K ﹤0.01%
250
-7,000
-97% -$188K
ILF icon
719
iShares Latin America 40 ETF
ILF
$3.76B
$8K ﹤0.01%
300
– –
NOK icon
720
Nokia
NOK
$52.3B
$8K ﹤0.01%
1,713
-321
-16% -$1.51K
RPRX
721
DELISTED
Repros Therapeutics Inc.
RPRX
$8K ﹤0.01%
6,000
– –
EXEL icon
722
Exelixis
EXEL
$13.4B
$7K ﹤0.01%
475
-1,975
-81% -$28.5K
JNPR
723
DELISTED
Juniper Networks
JNPR
$7K ﹤0.01%
244
– –
MRVL icon
724
Marvell Technology
MRVL
$196B
$7K ﹤0.01%
500
-1,000
-67% -$13.6K
ICAD
725
DELISTED
iCAD Inc
ICAD
$6K ﹤0.01%
2,000
– –
27 28
29
30 31

Similar funds

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $9.18B AUM 25.04% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Compagnie Lombard Odier SCmA's Q4 2016 Portfolio in Review

As of Q4 2016, Compagnie Lombard Odier SCmA held 900 positions worth $3.42B, down 0.27% from $3.43B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Compagnie Lombard Odier SCmA's Q4 2016 filing shows 2 new, 177 increased, 242 reduced and 88 closed positions. Its largest new stake was Telus: 3,800 shares worth $61K. The largest sale was Booking.com, an estimated $13.4M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Communication Services and Financials.

  • Compagnie Lombard Odier SCmA's largest Q4 2016 buy was Telus: 3,800 shares worth $61K.
  • Compagnie Lombard Odier SCmA added most to SLB Ltd in Q4 2016, an estimated $35.9M increase.
  • Compagnie Lombard Odier SCmA's biggest Q4 2016 reduction was Booking.com, cutting an estimated $13.4M.
  • Compagnie Lombard Odier SCmA fully exited iShares MSCI Japan ETF in Q4 2016, selling an estimated $4.57M.
  • Compagnie Lombard Odier SCmA's ten largest holdings make up 32% of its $3.42B portfolio in Q4 2016.
  • Compagnie Lombard Odier SCmA opened 2 new positions and closed 88 in Q4 2016.
  • Compagnie Lombard Odier SCmA's portfolio value fell 0.27% quarter-over-quarter to $3.42B.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2016, filed 14 Feb 2017.